about
A potential role for estrogen in cigarette smoke-induced microRNA alterations and lung cancerTackling ALK in non-small cell lung cancer: the role of novel inhibitorsNon-small cell lung cancer: current treatment and future advancesAnticoagulation, ferrotoxicity and the future of translational lung cancer researchLung cancer stem cells-characteristics, phenotypeThe role of the occupational therapist in the care of people living with lung cancerOvercoming toxicity-challenges in chemoradiation for non-small cell lung cancerThe importance of exercise in lung cancer treatmentThe lung cancer nurse role in the management of paraneoplastic syndromes in lung cancerThe role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerEpigenetics in non-small cell lung cancer: from basics to therapeuticsIs surgery still the optimal treatment for stage I non-small cell lung cancer?PiggyBac transposon vectors: the tools of the human gene encodingTargeted drugs in small-cell lung cancerSmall cell lung cancer (SCLC): no treatment advances in recent yearsTreatment for small cell lung cancer, where are we now?-a reviewCancer stem cells in small cell lung cancerCellular and molecular biology of small cell lung cancer: an overviewResults of clinical trials with anti-programmed death 1/programmed death ligand 1 inhibitors in lung cancerImmunotherapy meets targeted therapy: will this team end the war against cancer?Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysisProgrammed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta roleIntegrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicityPlatelets and their role in cancer evolution and immune systemCancer stem cells and immunoresistance: clinical implications and solutionsLung cancer in HIV-infected patients in the combination antiretroviral treatment eraCirculating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancerManagement of hyperglycemia from epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) targeting T790M-mediated resistanceImmune checkpoint inhibitors in clinical practice: update on management of immune-related toxicitiesNew strategies in immunotherapy for non-small cell lung cancerNovel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapiesNovel therapies in small cell lung cancerTreatment of advanced squamous cell carcinoma of the lung: a reviewAngiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC).Lung cancer biomarkers, targeted therapies and clinical assaysComputer modeling of lung cancer diagnosis-to-treatment processLung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysisLung cancer care: the impact of facilities and area measuresMeasuring improvement in populations: implementing and evaluating successful change in lung cancer careWhat is quality, and can we define it in lung cancer?-the case for quality improvement
P1433
Q26740327-39F7CA16-CEF7-4C64-A502-BD3E9A06ED16Q26740329-36E48851-0C9B-4C9E-913F-F6905A1A000FQ26740333-F0C92954-251F-4A28-A7DE-686F0A3BF9A8Q26740335-45D5DB00-9F05-4359-BBCC-98FF1436B87EQ26740338-8448C3AB-8C8D-4A69-9A96-01AF853D1508Q26740341-1B6BC534-9FD7-4320-BEF4-E20649C45244Q26740344-2B0C245D-F162-4BDE-A06F-CA7DAC74AAB9Q26740346-EC83F619-131E-43FC-BAF6-B46BB03AF271Q26740349-477CF3DE-4604-47CF-8623-97258E4739C9Q26749110-A4077163-1311-4E77-9521-40BC4927E7BEQ26749113-F6F97DD0-F5D9-49CC-ADD0-5A62B59A811FQ26749371-16BC1B94-174D-49B2-A844-34F022E67849Q26767014-8B09FE96-0C27-4601-AD91-3C980012D2DBQ26767017-E8648C1F-599C-49AE-A24E-FC05BFD87A0EQ26767020-4746AD3A-6264-48F6-8C97-25F86994564EQ26767023-E9489A51-66A5-45B6-B38C-F319E14F2619Q26767026-8265E40D-2F89-416E-A1FE-70AC705A2991Q26767029-5EADBCF3-FA57-4058-BAF2-E96ACA289E46Q26769713-6176E568-78F3-49C2-9B92-A34C70599902Q26769721-1C2D05D4-F1BF-4F1E-86A8-F9636BF4442FQ26769728-F7C7582E-10D0-4FB3-8DFC-1BE4CCF0AAB1Q26769734-5084A6ED-1EDD-4488-A01B-B2BD5C4AB377Q26769744-44753317-6E5F-456E-9A39-F82D69C01497Q26769754-562A31EA-B61F-4B7E-9964-03BEF0AD40A9Q26769757-8FFED76F-FB0D-4FB5-90CC-788AFEEFF702Q26769769-C8B2D7CA-891E-4991-8710-E3DCD5B6A50DQ26775376-4F65B2D0-71C8-4D24-B421-5D670A6422FAQ26775379-E6DCCFAC-27B4-4546-8984-85E95096AD8EQ26775383-2DDBCE96-6C6C-474C-ABCF-65D0E8198AD8Q26775385-3F80A4D8-58A8-469F-8E9F-E7AE69C18B94Q26775388-8DC44DAC-D16E-434F-9808-862DFC1ED3EDQ26775390-CBEC3DC0-8308-4C32-A0A7-7ACB06C2C437Q26775392-79FD918D-DCB4-422D-AEF5-D90B2B831E04Q26775394-155D966A-3A9B-4D61-9CE4-D5CD31687DD1Q26775396-B3918DB8-4685-465F-AB0C-68AD684D5894Q26784079-3885FF7E-1354-48F2-9F62-58BFE5D0D65AQ26784085-CD54C9ED-A279-4A86-9A10-CCBCC737BED4Q26784090-A4DA1A65-51A2-4FAD-882B-DC189B964998Q26784096-202256C4-76F5-44E1-8F59-699721111BE9Q26784103-E8CBEC0B-24E9-4738-BF5C-C9E44C843CAB
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Translational lung cancer research
@ast
Translational lung cancer research
@en
Translational lung cancer research
@es
Translational lung cancer research
@it
Translational lung cancer research
@nl
type
label
Translational lung cancer research
@ast
Translational lung cancer research
@en
Translational lung cancer research
@es
Translational lung cancer research
@it
Translational lung cancer research
@nl
prefLabel
Translational lung cancer research
@ast
Translational lung cancer research
@en
Translational lung cancer research
@es
Translational lung cancer research
@it
Translational lung cancer research
@nl
P1055
P1156
21100448905